Homocysteine lowering and cardiovascular events after acute myocardial infarction.

By K. Bønaa, I. Njølstad, P. Ueland, H. Schirmer, A. Tverdal, T. Steigen, Harald Wang, J. Nordrehaug, E. Arnesen, K. Rasmussen. New England Journal of Medicine, 2006

1,450 citations recorded by the source corpus.

Subfields: Clinical Biochemistry, Neurology, Rheumatology

View Paper: https://www.semanticscholar.org/paper/10939cafc6360fc138f4adbfd1f2dcb13e48614e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. G. Levine
2. E. Amsterdam
3. R. Brindis
4. N. Wenger
5. W. Hiatt
6. D. Casey
7. L. Norgren
8. D. Mukherjee

Citations in the corpus

• Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. (2008, background): “Vitamins which lower homocysteine (folate, B12, B6) do not appear to reduce stroke recurrence and may increase vascular events [298-301], but further trials are ongoing [302].”
• Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). (2007, background): “Two studies of supplemental B vitamins and folic acid in patients with CAD demonstrated no benefit and even a suggestion of harm, so this therapy cannot be recommended.(55,56)”
• 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014, background): “Folic acid, with or without vitamins B6 and B12, should not be used for secondary prevention in patients with NSTE-ACS (256,257).”
• Is folic acid good for everyone? (2008, background): “vitamins B-12 and B6 (70) or with folic acid (1 mg/d) alone (32).”